Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection
Perspective
[키워드] 2019-nCoV
Cancer
caused
Cell
cellular processes
Central nervous system
CNS
country
COVID-19
COVID-19 pandemic
disorder
DNA damage
Drug repurposing
Evidence
Factor
global healthcare
homeostasis
Hospitalization
Host
human disease
increasingly
indicate
Infection
microRNA
miRNA
mutant
Neuropathology
non-coding RNA
novel coronavirus SARS-CoV-2
PARP-1
pathogenic
pathological outcomes
Pathologies
pathology
Perspective
recent finding
Regulation
RNA viruses
SARS-CoV-2
SARS-CoV-2 life cycle
Significance
significant increase
survival
therapeutic potential
Therapeutics
urgency
virus
[DOI] 10.3390/ncrna7040060 PMC 바로가기 [Article Type] Perspective
[DOI] 10.3390/ncrna7040060 PMC 바로가기 [Article Type] Perspective